Peter M. Rothwell

TL;DR: The results reaffirm use of the 3‐month mRS outcome in stroke trials and demonstrate translation of early disability gains into additional reductions in long‐term mortality without much erosion by non‐stroke‐related deaths.

TL;DR: In this article , a cross-ancestry GWAS meta-analyses of 110,182 patients who have had a stroke (five ancestries, 33% non-European) and 1,503,898 control individuals, identify association signals for stroke and its subtypes at 89 (61 new) independent loci: 60 in primary inverse-variance-weighted analyses and 29 in secondary meta-regression and multitrait analyses.

TL;DR: The effect of age and glycaemic control on the relationship between fibrinogen and risk of acute coronary events supports the hypothesis of a causal effect of fibr inogen mediated via the permeability offibrin clot.

TL;DR: The Synergium was to devise and prioritize new ways of accelerating progress in reducing the risks, effects, and consequences of stroke by using a ‘Brain Health’ concept that enables promotion of preventive measures.

TL;DR: The introduction and use of the STROND checklist should lead to more consistent, transparent, and contextualized reporting of descriptive neuroepidemiologic studies resulting in more applicable and comparable findings and ultimately support better health care decisions.